Becton Dickinson to Split from Bioscience and Diagnostic Solutions Arms
American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...
Hosted on MSN7h
Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $3.43 per share, beating the Zacks Consensus Estimate of $2.98 per share. This compares to earnings of $2.68 per share a year ago. These ...
Zacks.com on MSN8h
Compared to Estimates, Becton Dickinson (BDX) Q1 Earnings: A Look at Key Metrics
For the quarter ended December 2024, Becton Dickinson (BDX) reported revenue of $5.17 billion, up 9.8% over the same period last year. EPS came in at $3.43, compared to $2.68 in the year-ago quarter.
Becton, Dickinson And Company Q1 Profit Increases, Beats Estimates
Becton, Dickinson and Company (BDX) reported earnings for its first quarter that increased from the same period last year and beat ...
Becton Dickinson & Co. stock outperforms competitors on strong trading day
Becton Dickinson & Co. closed 2.75% below its 52-week high of $251.99, which the company reached on February 3rd.
Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business
Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...